Overview Fundamentals API Earnings EOD API Sample Code Pricing

ORIC PHARMAC.INC.DL-0001 (4TZ F) stock market data APIs

€7.8 0(0%) as of October 29, 2024
Price chart is built with Anychart

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, which is designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study; and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, currently under Phase 1b study, being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms, including ORIC-613, an orally bioavailable, highly selective inhibitor of PLK4, in preclinical studies for the treatment of breast cancers. It has a license and collaboration agreement with Voronoi Inc.; a license agreement with Mirati Therapeutics, Inc.; and clinical development collaboration agreement with Pfizer Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

ORIC PHARMAC.INC.DL-0001 Financial Data Overview

7.8
7.8
-
7.8
7.8
5.8-14.8
625 M
70 542 K
0
1.108
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '4TZ',
Type: 'Common Stock',
Name: 'ORIC PHARMAC.INC.DL-0001',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
CUSIP: NULL,
}

ORIC PHARMAC.INC.DL-0001 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -124 064 000
  • Earnings Per Share -1.63
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get ORIC PHARMAC.INC.DL-0001 Earnings via APIs

  • Latest Release 2024-11-04
  • EPS/Forecast NaN

Get ORIC PHARMAC.INC.DL-0001 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com